Different imprinting status of IGF-2 in epithelial ovarian tumors

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 22, Issue 3, 2002, Pages 255-256

  Xiong, Yali ^a   Sun, Yongyu ^a   Li, Hongfa ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epithelial ovarian tumor; Genomic imprinting; IGF 2

Indexed keywords

EPITHELIAL OVARIAN TUMORS; GENOMIC IMPRINTING; POLYMORPHISM;

DIAGNOSIS; DNA; GENES; RNA;

TUMORS;

SOMATOMEDIN B;

ARTICLE; CYSTADENOCARCINOMA; CYSTADENOMA; FEMALE; GENETICS; GENOME IMPRINTING; HUMAN; OVARY TUMOR;

CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA; FEMALE; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; OVARIAN NEOPLASMS;

EID: 0642317052     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Feinberg AP. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res, 1999, 59(7 Suppl):1743
2. Cui H, Niemitz EL, Ravenel JD et al. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res, 2001,61(13):4947
3. Niikawa N. Genomic imprinting relevant to genetic disease. Southeaset Asian J Trop Med Public Health, 1997,28 Suppl 3:46
4. O'Dell SD, Day IN. Insulin-like growth factor II(IGF-II). Int J Biochen Cell, 1998,30(7):767
5. Harris TM. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice. Oncogene, 1998,16(2): 203